Fidaxomicin for Initial Episode of <i>Clostridioides difficile</i> Infection Reduces Recurrence in Immunocompromised Hosts-a Large Retrospective Cohort Study. [PDF]
Atamna A +5 more
europepmc +1 more source
Reducing the incidence of <i>Clostridioides difficile</i> infection through educational and antimicrobial stewardship interventions. [PDF]
Nagaoka H +11 more
europepmc +1 more source
<i>Clostridioides difficile</i> infection in pediatric inflammatory bowel disease: current understanding and clinical challenges. [PDF]
Rogalidou M.
europepmc +1 more source
Fulminant Clostridioides difficile Infection During Repeated High-Dose Cytarabine Consolidation for Acute Myeloid Leukemia: A Fatal Case. [PDF]
Iwanaga E +4 more
europepmc +1 more source
Rectal Fidaxomicin as Salvage Therapy in Fulminant <i>Clostridioides difficile</i> Infection After Total Colectomy: A Case Report. [PDF]
Alok A +4 more
europepmc +1 more source
Burden of Clostridioides difficile Infection and Risk Factors for Recurrences in an Italian Tertiary Care University Hospital: A Prospective Observational Study. [PDF]
Gagliano MC +15 more
europepmc +1 more source
Compassionate Use of Encapsulated MKB-01 Fecal Microbiota Transplantation for Recurrent <i>Clostridioides difficile</i> Infection: A Single-Center Experience. [PDF]
Cano Á +9 more
europepmc +1 more source
Trends and Efficacy in Clostridioides difficile Infection Management at a Polish Clinical Hospital. [PDF]
Drobnik J +4 more
europepmc +1 more source
<i>In Vitro</i> Activity of Sulfamethoxazole-Trimethoprim, Amikacin, Oxazolidinones, Fluoroquinolones and Fidaxomicin against Isolates of <i>Nocardia</i>. [PDF]
Wang C +11 more
europepmc +1 more source
What should infectious diseases clinicians know about pharmacy benefit managers and their impact on our patients? [PDF]
Raja K +6 more
europepmc +1 more source

